Financial Services, Investments, Latvia, Markets and Companies, Medicine

International Internet Magazine. Baltic States news & analytics Friday, 26.04.2024, 15:41

AmberStone Group acquires 22.66% of Grindeks total share capital

BC, Riga, 20.07.2015.Print version
The holding company AmberStone Group has acquired 22.66% of the total share capital in the Latvian pharmaceutical company Grindeks, according to a Grindeks report submitted to the Nasdaq Riga Stock Exchange, cites LETA.

AmberStone Group is a holding company established in 2013. It owns several subsidiaries that work in various industries. Its main long-term financial goal is to increase the value of the entire group, as well as the sustainability and stability of its subsidiaries. AmberStone Group has 103 shareholders, the largest of which is ABLV Bank with 24.64% of shares.

 

Up until now, 22.66% of Grindeks voting rights belonged to "ABLV Private Equity Fund 2010".

 

On July 17th, Grindeks received a notification from "ABLV Private Equity Fund 2010" about a loss of direct significant participation in shareholding. According to this notification, "ABLV Private Equity Fund 2010" on July 15 lost a direct significant shareholding in Grindeks by losing its proportion of voting rights from 2,172,437 shares, which constitutes 22.66% of Grindeks total share capital.

 

Grindeks concluded last year with EUR 2.5 million losses. In 2013, the group's net profit reached EUR 13.5 million. The group's turnover in 2014 was EUR 88.5 million, which is EUR 30 million or 25% less than in 2013.






Search site